Data as of Mar 13
| +0.30 / +2.09%|
The 4 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 20.00, with a high estimate of 40.00 and a low estimate of 19.00. The median estimate represents a +36.33% increase from the last price of 14.67.
The current consensus among 4 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.